Clusterin is also upregulated in the glomeruli of adult patients with kidney disease, including diabetic nephropathy, and it is believed to have a protective role against oxidative stress and to protect podocytes against oxidative stress-induced apoptosis [64,65]. Here, CLU is linked to diabetic kidney disease.